Portable ultrasound vendor SonoSite topped the $10 million mark in revenues in its first year since being spun off by ATL. Not surprisingly, the bulk of those revenues came in the fourth quarter (end-December), following launch of the Bothell, WA-based
Portable ultrasound vendor SonoSite topped the $10 million mark in revenues in its first year since being spun off by ATL. Not surprisingly, the bulk of those revenues came in the fourth quarter (end-December), following launch of the Bothell, WA-based companys first two commercial product platforms, the SonoSite 180 hand-held ultrasound system and the SonoHeart hand-held echocardiography system (SCAN 9/29/99 and 1/12/00). SonoSite began shipping SonoHeart this month.
Despite revenues of $9.4 million for the fourth quarter and $10.1 million for the year, SonoSite still reported hefty losses at years end: Losses for the year were $21.6 million, compared to $13 million for 1998. This was due in part to increases in operating expenses related to product and personnel ramp-up in support of the companys new product lines. Fourth-quarter losses reflect the companys new revenue streams, however; losses for the quarter were $3.2 million, compared to losses of $4.7 million for the fourth quarter of 1998.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.